|Organization:||National Cancer institute, MD, US|
|I.P. Brief:||Intellectual Property to be covered includes unlicensed inventions of nanoparticulate technologies for therapeutics, drug delivery; computational design of bionanoparticles; imaging; and nano-scale technologies for the detection and sequencing of nucleotide sequences.|
|Keywords:||nanoparticle, metastasis, cancer, therapeutic, diagnostic, carbohydrate, nanobiology, peptide|
|Primary Industry:||Health & Medical Devices|
|Specific Market:||Cancer therapeutics and diagnostics|
Full IP Descriptions available on-site.